Sutro Biopharma Net Asset Quality Index
Sutro Biopharma net asset quality index. Sutro Biopharma (STRO) has a Net Asset Quality Index of -53.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $194.46 Million minus total liabilities of $297.78 Million yields net assets of $-103.32 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Sutro Biopharma book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sutro Biopharma (2016–2025)
Net asset quality index of Sutro Biopharma from 2016 to 2025. This chart shows how Sutro Biopharma's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at -53.1%, representing net assets of $-103.32 Million against total assets of $194.46 Million USD. Check Sutro Biopharma (STRO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Sutro Biopharma Net Asset Quality Index by Year (2016–2025)
Sutro Biopharma net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Sutro Biopharma from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see STRO stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -76.2% | $-132.45 Million | $173.83 Million | $306.28 Million | ▼ -87.7 pp |
| 2024 | 11.5% | $44.60 Million | $387.21 Million | $342.61 Million | ▼ -20.3 pp |
| 2023 | 31.8% | $149.65 Million | $470.74 Million | $321.09 Million | ▼ -21.5 pp |
| 2022 | 53.3% | $217.05 Million | $406.94 Million | $189.90 Million | ▼ -20.6 pp |
| 2021 | 74.0% | $252.56 Million | $341.41 Million | $88.84 Million | ▼ -10.3 pp |
| 2020 | 84.3% | $332.05 Million | $394.11 Million | $62.06 Million | ▲ +21.7 pp |
| 2019 | 62.5% | $97.79 Million | $156.37 Million | $58.58 Million | ▲ +3.6 pp |
| 2018 | 58.9% | $131.54 Million | $223.14 Million | $91.60 Million | ▲ +326.3 pp |
| 2017 | -267.4% | $-109.00 Million | $40.77 Million | $149.77 Million | ▼ -136.1 pp |
| 2016 | -131.2% | $-90.90 Million | $69.28 Million | $160.18 Million | — |